F.D.A. Approves Merck’s Combination Drug to Reduce Cholesterol

Saturday, May 4, 2013 - 00:10 in Health & Medicine

The drug pairs Merck’s Zetia, which lowers low-density lipoprotein, with the generic version of Lipitor, the best-selling statin made by Pfizer that lost its patent protection in 2011.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net